Orgil Pharma Private Limited
About Orgil Pharma Private Limited
Data last updated:
Orgil Pharma Private Limited is a private limited company based in Hissar, Haryana, India. It operates in the repair services segment of the electronics sector. It was incorporated on 13 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U52609HR2020PTC085806.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Hari Krishan Khanna and Suryansh Khanna.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 9 Katla Market Near Juthra Dharmshala, Hissar, Haryana, India – 125001.
As per the financials filed for FY 2025, the company reported a revenue of ₹90,168, a decline of 58% compared to the previous year. For the same year it recorded a net loss of ₹8,597 (net margin -9.5%) and EBITDA of -₹8,597 (EBITDA margin -9.5%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address9 Katla Market Near Juthra Dharmshala, Hissar, Haryana, India – 125001
- IndustryElectrnoics, Repair Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Orgil Pharma Private Limited
The main business activity of Orgil Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Orgil Pharma Private Limited FY 2025 filings available
Orgil Pharma Private Limited reported revenue of ₹90,168 (down 58% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Orgil Pharma Private Limited
Revenue fell 58% in the latest year. EBITDA fell 238% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Orgil Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹8,597 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹8,597 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Orgil Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -9.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Orgil Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Orgil Pharma Private Limited
Orgil Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Borjai Crop Solutions Private Limited | ₹91,008 (FY 2025) | •••• | •••• | -73.0% | •••• | Haveli, Maharashtra, India |
| Anagh Api Private Limited | ₹90,635 (FY 2025) | •••• | •••• | 189.0% | •••• | Anand, Gujarat, India |
| Valson Chemicals (OPC) Private Limited | ₹90,601 (FY 2025) | •••• | •••• | -96.0% | •••• | Bhavnagar, Gujarat, India |
| Nyarchem Private Limited | ₹90,520 (FY 2021) | •••• | •••• | -88.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Goodwin Medicine(India) Pharmaceuticals Private Limited | ₹90,327 (FY 2024) | •••• | •••• | 902.0% | •••• | Bilaspur, Chattisgarh, India |
| Orgil Pharma Private Limited this company | ₹90,168 (FY 2025) | •••• | •••• | -58.0% | •••• | Hissar, Haryana, India |
| Vitsupp Healthcare Private Limited | ₹90,044 (FY 2017) | •••• | •••• | 236.0% | •••• | Delhi, India |
| Renaisso Pharma Private Limited | ₹90,027 (FY 2021) | •••• | •••• | 13029.0% | •••• | Nawabganj, Uttar Pradesh, India |
| Fulgro Biogreen Private Limited | ₹90,000 (FY 2022) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Triton Bio-Chemicals Private Limited | ₹90,000 (FY 2024) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Silicon Fertilizer Limited | ₹90,000 (FY 2025) | •••• | •••• | -64.0% | •••• | Iyava, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Orgil Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Orgil Pharma Private Limited
Orgil Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hari Krishan Khanna | Director | 13 Mar 2020 | 6 Years 6 Months | Current |
| Suryansh Khanna | Director | 13 Mar 2020 | 6 Years 6 Months | Current |
Charges & Borrowings of Orgil Pharma Private Limited
Orgil Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Orgil Pharma Private Limited
Employment history and EPFO contributions of people linked to Orgil Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Orgil Pharma Private Limited
Orgil Pharma Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Hari Krishan Khanna was appointed as Director on 13 Mar 2020.
Credit Ratings, Litigation & Regulatory Alerts for Orgil Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Orgil Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Orgil Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Orgil Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Orgil Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orgil Pharma Private Limited
Orgil Pharma is an active private limited company based in Hissar, Haryana, India. The company works in repair services, within the electronics industry. It was incorporated on 13 March 2020 (6+ years old) and is registered under CIN U52609HR2020PTC085806.
Orgil Pharma reported revenue of ₹90,168 for FY 2025 (down 58% YoY).
Orgil Pharma has 2 current directors:
- Hari Krishan Khanna - Director
- Suryansh Khanna - Director
Orgil Pharma reported a net loss of ₹8,597 (net margin -9.5%) and EBITDA of -₹8,597 (EBITDA margin -9.5%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Orgil Pharma is U52609HR2020PTC085806. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orgil Pharma was incorporated on 13 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Orgil Pharma by revenue are Borjai Crop Solutions Private Limited, Anagh Api Private Limited, Valson Chemicals (OPC) Private Limited, Nyarchem Private Limited, Goodwin Medicine(India) Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hari Krishan Khanna was appointed as Director on 13 Mar 2020. Suryansh Khanna was appointed as Director on 13 Mar 2020.
The registered office of Orgil Pharma is at 9 Katla Market Near Juthra Dharmshala, Hissar, Haryana, India – 125001.
Orgil Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.
Orgil Pharma operates in the electronics industry, in the repair services segment.